Search

everythinglearnresearchcommunity

for

Search:↓

Inhibiting certain proteins harms hair follicle immunity and increases IL-33, affecting hair health.

The study found that androgen receptors in skin cells mainly affect the focal adhesion pathway and control the caveolin-1 gene, with implications for new treatments for related diseases.

Combining ficlatuzumab and gefitinib can cause severe scarring hair loss.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

Recurrent NICF is a rare skin condition with unclear causes, involving follicle inflammation and crystal deposits.

A man's severe skin reaction from cancer treatment improved with early diagnosis and proper medication.

You might not need to stop cancer treatment if you get a rare skin reaction from EGFR inhibitors, as skin treatments can help manage it.

Injury boosts normal skin cell growth, reducing cancer cell advantage.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Lasers can help reduce skin side effects from cancer treatment.

Removing Lrig1-positive cells in mice leads to temporary loss of sebaceous glands.

Sesamin may help treat hair loss by affecting specific cell pathways.

Baicalin may effectively treat hair loss by inhibiting 5α-reductase.

Lithium chloride-treated stem cell exosomes boost hair growth by activating a specific pathway.

Dacomitinib can cause nail and skin issues, but these can be managed without stopping the drug.

Erosive pustular dermatosis of the scalp can occur about 17 weeks after starting EGFR inhibitors, and early minocycline may help manage it.

An extremely low-birthweight infant had a rare genetic skin disease and died despite treatment.

Young women in West Bengal, India, with PCOS often have estrogen resistance, leptin receptor issues, folate deficiency, T2DM, and acanthosis, commonly linked to obesity.

A compound from Calophyllum inophyllum L. leaf may help treat non-small cell lung cancer.

N6-methyladenosine affects hair follicle development differently in Rex and Hycole rabbits.

Blocking EGFR can lead to hair loss due to inflammation and stem cell damage.

Disrupting a specific protein's function in hair follicle stem cells triggers their activation and a self-healing process.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Loss of the p53 gene alone causes tumors, and losing both p53 and Rb genes speeds up aggressive skin cancer.

Loss of the p53 gene alone causes tumors, and losing both p53 and Rb genes speeds up aggressive skin cancer.

Drug repurposing shows promise for treating many medical conditions.

Decreasing MIG6 can increase the movement and invasiveness of MEK-inhibited mutant NRAS melanoma, particularly when stimulated by EGF.

SOX4 is crucial for the development of melanoma.

EGFR helps hair follicles transition properly by controlling Stathmin levels.